Conatus launches IPO, price dips on first trading day
This article was originally published in Scrip
Executive Summary
Conatus Pharmaceuticals had a rocky first day on the Nasdaq, since the company priced its initial public offering at $11 per share, but closed down 13.6% at $9.50.